XML 47 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity (Tables)
 6 Months Ended
Feb. 28, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Recognized Stock-based Compensation Expense
The Company recognized stock-based compensation expense within selling, general and administrative expense as follows (in millions):
  Three months ended Six months ended
  February 28, 2023 February 28, 2022 February 28, 2023 February 28, 2022
Restricted stock units
 $ 16  $ 12  $ 54  $ 44 
Employee stock purchase plan 4  4  8  7 
Total $ 20  $ 16  $ 62  $ 51 
Schedule of Share-based Compensation Information
The following represents the stock-based compensation information as of the period indicated (in millions):
  February 28, 2023
Unrecognized stock-based compensation expense—restricted stock units $ 64 
Remaining weighted-average period for restricted stock units expense 1.5 years
Schedule of Common Stock Outstanding
The following represents the common stock outstanding for the periods indicated:
Three months ended Six months ended
February 28, 2023 February 28, 2022 February 28, 2023 February 28, 2022
Common stock outstanding:
Beginning balances
 134,231,300  144,166,009  135,493,980  144,496,077 
Shares issued under employee stock purchase plan
 629,336  520,483  629,336  520,483 
Vesting of restricted stock
 148,718  28,243  2,010,396  2,453,715 
Purchases of treasury stock under employee stock plans
 (47,242) (9,719) (570,649) (700,274)
Treasury shares purchased(1)(2)
 (1,723,744) (2,312,881) (4,324,695) (4,377,866)
Ending balances
 133,238,368  142,392,135  133,238,368  142,392,135 
(1)In July 2021, the Board of Directors approved an authorization for the repurchase of up to $1.0 billion of the Company’s common stock (the “2022 Share Repurchase Program”). As of February 28, 2023, 16.5 million shares had been repurchased for $1.0 billion and no authorization remains under the 2022 Share Repurchase Program.
(2)In September 2022, the Board of Directors approved an authorization for the repurchase of up to $1.0 billion of the Company’s common stock (the “2023 Share Repurchase Program”). As of February 28, 2023, 0.3 million shares had been repurchased for $25 million and $975 million remains available under the 2023 Share Repurchase Program.